« Previous
Next »
Titles
- Notifying FDA of a permanent discontinuance or interruption in manufacturing of a device under Section 506J of the FD&C Act: guidance for industry and Food and Drug Administration staff1
- Notifying FDA of a permanent discontinuance or interruption in manufacturing under section 506C of the FD&C Act1
- Nucleic acid testing (NAT) for human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV): testing, product disposition, and donor deferral and reentry1
- Nurse Corps Loan Repayment Program: too early to determine effects of allowing recipients to serve at for-profit facilities : report to Congressional committees1
- Nursing home quality: continued improvements needed in CMS's data and oversight : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives1
- Nursing homes in rural America: a chartbook : key facts about nursing home availability in rural America1
- Nursing homes reported wide-ranging challenges preparing for public health emergencies and natural disasters1
- Nursing homes: CMS should make ownership information more transparent for consumers : report to the Honorable Richard Neal, House of Representatives1
- Nursing homes: Limitations of using CMS data to identify private equity and other ownership : report to the Ranking Member, Committee on Ways and Means, House of Representatives1
- Nursing homes: better oversight needed to protect residents from abuse : statement for the record to the Committee on Ways and Means, House of Representatives1
